Maternal serum SPARCL-1 levels in preeclampsia: Diagnostic performance by onset subtype
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Vascular endothelial-derived SPARCL1 exacerbates viral pneumonia through pro-inflammatory macrophage activationNature Communications, 2024
- 2023 ESH Guidelines. What are the main recommendations?European Journal of Internal Medicine, 2023
- Preeclampsia: Pathophysiology and managementJournal of Gynecology Obstetrics and Human Reproduction, 2021
- Matricellular Protein SPARCL1 Regulates Blood Vessel Integrity and Antagonizes Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2021
- SPARCL1 impedes trophoblast migration and invasion by down-regulating ERK phosphorylation and AP-1 production and altering EMT-related molecule expressionPlacenta, 2020
- Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected PreeclampsiaNew England Journal of Medicine, 2016
- International standards for early fetal size and pregnancy dating based on ultrasound measurement of crown–rump length in the first trimester of pregnancyUltrasound in Obstetrics & Gynecology, 2014
- Pre‐eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn HealthBJOG: An International Journal of Obstetrics & Gynaecology, 2014
- The Two Stage Model of Preeclampsia: Variations on the ThemePlacenta, 2009
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004